NCT02361866View on ClinicalTrials.gov

To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Bacterial Infections
Interventions
BIOLOGICAL

GC1107

0.5 ml, Intramuscular, single dose(day0)

BIOLOGICAL

Tetanus and Diphtheria(Td vaccine)

0.5ml, Intramuscular, single dose(day0) only applicable step1

Trial Locations (1)

1544-9004

Incheon St. Mary's Hospital Catholic Univ., Incheon

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY